BioSig Technologies Signs Agreement with Texas Cardiac Arrhythmia Institute for First–in-Human Studies

Santa Monica, CA, Nov. 27, 2018 - BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company has signed an agreement with Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center in Austin, Texas, to conduct First-in-Human studies using the PURE EP™ System.

Nuance’s AI Marketplace Delivers AI at Scale with Industry’s First Workflow-Integrated Market for Diagnostic Imaging Algorithms

Collaborative community of developers, publishers, data scientists, and radiologists can seamlessly create, distribute, and utilize continuously learning algorithms for 25,000 radiologists across 5,500 connected healthcare facilities

RSNA 2018: The value of automated recommendations in AI radiology reporting

untitled.jpg

Tarik K. Alkasab, MD, PhD. 

As time goes on, artificial intelligence (AI) is becoming more widely accepted as a necessary component of clinical workflow in medical imaging. According to Tarik K. Alkasab, MD, PhD, a radiologist at Massachusetts General Hospital in Boston, AI has the potential to make radiology reporting much more consistent and ultimately help radiologists make smarter decisions.

Readmissions common, costly after ablation of MI-associated VT

Almost 1 in 5 patients are rehospitalized within 30 days of undergoing catheter ablation of MI-associated ventricular tachycardia (VT), according to a study from the Nationwide Readmissions Database. These patients rack up 38.9 percent higher cumulative hospital costs than those who aren’t readmitted, researchers reported in Circulation: Arrhythmia and Electrophysiology.